Knowledge for Growth 2026

Event type: Biotechnology, Life Sciences, Pharma Innovation, Research Collaboration, Investor Networking, Licensing, Business Development

Estimated attendance: Expected to attract a highly targeted B2B audience of biotech innovators, pharma executives, research organizations, investors, academic partners, service providers, and global business development teams.

Audience profile: This is a specialized life sciences and biotechnology networking event designed for decision-makers involved in R&D, partnerships, commercialization, fundraising, licensing, technology transfer, and strategic collaboration.

1️⃣ Who attends: Buyers / attendees

Knowledge for Growth 2026 is not a broad consumer expo. It is a premium industry networking environment where the strongest buyer signals come from biotech and pharma leadership teams, research institutions, investors, incubators, and companies looking to source innovation, partnerships, and commercial opportunities.

The most valuable attendees are typically:

• Biotech founders, CEOs, and managing directors
• Business development and licensing leaders
• R&D heads, innovation directors, and scientific program managers
• Pharma and medtech partnership teams
• Technology transfer officers and academic commercialization leaders
• Investors, venture capital professionals, and corporate development teams
• Lab service providers, CROs, CDMOs, and diagnostics companies
• Government innovation agencies, accelerators, and cluster organizations

From a buyer-list perspective, this kind of event is especially valuable because the attendees are usually not general visitors; they are people with budget, partnership influence, innovation mandates, or direct responsibility for sourcing external solutions.

2️⃣ Where the show is happening + attendee geographic origin

Location: The event is typically associated with the biotech and life sciences ecosystem in Europe, often drawing strong participation from Belgium, the Netherlands, France, Germany, the UK, Switzerland, and other innovation-heavy markets.

Attendee origin: The audience is usually international, with a strong concentration from Europe and a meaningful presence from global biotech hubs such as the United States, Israel, Singapore, and other innovation-led markets. This makes the event attractive for companies seeking cross-border partnerships, licensing, investment, and business development opportunities.

If your client is looking for a geographically diverse life sciences buyer pool, this event is a strong candidate because the attendees are often already operating in cross-border research, commercialization, and collaboration networks.

3️⃣ Audience reach

Reach type: Regional to Global

The event has a strong European base, but its buyer value extends globally because biotechnology, pharma innovation, diagnostics, and research collaboration are inherently international markets. Attendees are often looking beyond their home country for funding, partnerships, service vendors, research platforms, distribution, and strategic alliances.

In practical terms, this means the event is well suited for companies selling into:

• Biotech and pharma decision-makers
• Research and laboratory organizations
• Investment and innovation ecosystems
• Healthcare technology and life sciences services
• Academic and translational research networks

4️⃣ Sample buyer company names + websites

Below is a buyer-focused sample list of companies that represent strong fit accounts for this event. These are the types of organizations that are likely to attend, sponsor, exhibit, partner, or actively buy services and solutions related to biotechnology, life sciences, pharma innovation, diagnostics, lab infrastructure, and commercialization.

Top 5 best sample accounts to send first: Johnson & Johnson, Pfizer, Novartis, Roche, Thermo Fisher Scientific.

5️⃣ Job profiles, industries & event type

Best job profiles to target:

• CEO / Founder / Managing Director
• Chief Business Officer
• VP Business Development
• Head of Innovation
• Director, Licensing & Partnerships
• Alliance Management Director
• R&D Director
• Scientific Affairs Lead
• Technology Transfer Officer
• Investment Manager / Venture Partner
• Commercialization Director
• Lab Services Sales Director
• Product Strategy Manager
• Corporate Development Director
• Medical Affairs / Innovation Collaboration Lead

Best industry categories to use from the industry list:

• Biotechnology
• Pharmaceuticals
• Medical Devices
• Research
• Information Services
• Information Technology & Services
• Hospital & Health Care
• Health, Wellness & Fitness
• Management Consulting
• Venture Capital & Private Equity
• Investment Management
• Higher Education
• Professional Training & Coaching
• International Trade & Development
• Marketing & Advertising for ecosystem and agency-side participants

This event is particularly powerful for products and services sold into biotech innovation ecosystems, including lab platforms, research tools, scientific software, consulting, CRO/CDMO services, IP/legal support, fundraising services, and commercialization solutions.

6️⃣ Estimated attendance / expected footfall

While exact attendance can vary by year, a specialized event like Knowledge for Growth typically generates a high-quality but concentrated footfall rather than mass-market volume. The real value is not raw crowd size alone; it is the density of decision-makers.

A reasonable expectation is:

• Strong presence of biotech and pharma executives
• Multiple networking tracks and business meetings
• High concentration of exhibitors, partners, and investors
• Significant participation from innovation ecosystems and academic institutions

For attendee-list use cases, this means the event can produce a high-value database if filtered correctly by function, seniority, and industry relevance.

7️⃣ Key focus areas & buyer engagement

Core focus areas:

• Biotech innovation and pipeline development
• Drug discovery and development partnerships
• Diagnostics, genomics, and lab technologies
• Startup funding and venture creation
• Licensing, commercialization, and IP
• Academic-industry collaboration
• Cross-border business development
• Scientific networking and ecosystem building

Best buyer engagement angle:

The strongest outreach message is not to position this as a general attendee list. It should be framed as a high-value life sciences decision-maker audience. A better angle would be:

“We can help you reach biotech founders, pharma innovation leaders, licensing teams, R&D decision-makers, investors, and commercialization professionals actively engaged in global life sciences growth.”

That language is much stronger because it focuses on strategic buying power, not just event participation.

8️⃣ Client-product fit note

Before finalizing the best buyer list, it is important to review your client’s website and product offering. The best buyers for this event depend heavily on what your client sells.

• If your client sells scientific software, data platforms, or lab automation, target R&D leaders, research institutions, diagnostics companies, and biotech operations teams.
• If your client sells fundraising, consulting, or advisory services, target founders, CEOs, venture-backed startups, investors, and corporate development teams.
• If your client sells lab equipment, testing, or consumables, target procurement-aligned lab managers, scientific operations leaders, and research service companies.
• If your client sells marketing, lead generation, or attendee engagement services, target exhibitors, sponsors, accelerators, and ecosystem organizations.
• If your client sells recruitment or staffing solutions, target biotech HR, talent acquisition, and workforce planning leaders.

If you share the client website, I can refine this into a more precise buyer shortlist and prioritize the strongest targets based on product-market fit.

9️⃣ Final recommendation

Knowledge for Growth 2026 is a strong event for targeted B2B attendee-list research, especially if your client wants access to the biotech, pharma, diagnostics, research, and innovation ecosystem. It is particularly valuable for companies selling into high-level decision-makers rather than general event attendees.

Best buyer segments to collect:

• Biotech founders and CEOs
• Business development and licensing leaders
• R&D and innovation directors
• Investor and venture capital contacts
• Academic commercialization and technology transfer officers
• Lab services, diagnostics, and scientific platform providers
• Pharma partnership and alliance teams

Overall quality rating for B2B attendee-list sales: 9/10

This is a highly relevant event for life sciences buyer intelligence because it concentrates senior, commercially relevant, innovation-driven professionals in one environment. The only thing that determines final list quality is how well the audience is filtered to match your client’s product category.

Next step: Share your client website, and I can review it and identify the best buyer personas, companies, industries, and job titles for this event.